• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

作者信息

De Backer Guy, Ambrosioni Ettore, Borch-Johnsen Knut, Brotons Carlos, Cifkova Renata, Dallongeville Jean, Ebrahim Shah, Faergeman Ole, Graham Ian, Mancia Giuseppe, Manger Cats Volkert, Orth-Gomér Kristina, Perk Joep, Pyörälä Kalevi, Rodicio José L, Sans Susana, Sansoy Vedat, Sechtem Udo, Silber Sigmund, Thomsen Troels, Wood David

机构信息

University Hospital, DePintelaan 185, B-9000 Ghent, Belgium.

出版信息

Eur Heart J. 2003 Sep;24(17):1601-10. doi: 10.1016/s0195-668x(03)00347-6.

DOI:10.1016/s0195-668x(03)00347-6
PMID:12964575
Abstract
摘要

相似文献

1
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.欧洲临床实践中心血管疾病预防指南。欧洲及其他学会心血管疾病预防临床实践联合工作组第三次报告
Eur Heart J. 2003 Sep;24(17):1601-10. doi: 10.1016/s0195-668x(03)00347-6.
2
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).欧洲临床实践心血管疾病预防指南：执行摘要：欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第四次报告（由九个学会的代表及特邀专家组成）
Eur Heart J. 2007 Oct;28(19):2375-414. doi: 10.1093/eurheartj/ehm316. Epub 2007 Aug 28.
3
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force Of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).欧洲临床实践中心血管疾病预防指南。欧洲及其他学会心血管疾病预防临床实践联合工作组第三次报告（由八个学会的代表及特邀专家组成）。
Arch Mal Coeur Vaiss. 2004 Oct;97(10):1019-30.
4
[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation].[2016年欧洲临床实践心血管疾病预防指南。欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第六版（由10个学会的代表及特邀专家组成。在欧洲心血管预防与康复协会的特别贡献下制定）]
G Ital Cardiol (Rome). 2017 Jul-Aug;18(7):547-612. doi: 10.1714/2729.27821.
5
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》（2012年版）。欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第五版（由九个学会的代表及特邀专家组成）。
Eur Heart J. 2012 Jul;33(13):1635-701. doi: 10.1093/eurheartj/ehs092. Epub 2012 May 3.
6
[European Guidelines on Cardiovascular Disease Prevention in the Clinical Practice. Third work group of the european societies and other societies on cardiovascular disease prevention in the clinical practice].[欧洲临床实践心血管疾病预防指南。欧洲各学会及其他学会临床实践心血管疾病预防第三工作组]
Neurologia. 2004 Oct;19(8):440-50.
7
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).欧洲临床实践中心血管疾病预防指南：执行摘要。欧洲心脏病学会和其他学会关于临床实践中心血管疾病预防的第四联合工作组（由九个学会的代表和特邀专家组成）。
Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:E1-40. doi: 10.1097/01.hjr.0000277984.31558.c4.
8
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》（2012年版）：欧洲心脏病学会及其他学会关于临床实践心血管疾病预防的第五联合工作组（由九个学会的代表及特邀专家组成）
Eur J Prev Cardiol. 2012 Aug;19(4):585-667. doi: 10.1177/2047487312450228. Epub 2012 Jul 4.
9
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南：欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组（由10个学会的代表和特邀专家组成），由欧洲心血管预防与康复协会（EACPR）特别贡献制定。
Atherosclerosis. 2016 Sep;252:207-274. doi: 10.1016/j.atherosclerosis.2016.05.037.
10
[Guidelines on cardiovascular disease prevention in clinical practice. Belgian Working Group on Cardiovascular Prevention and Rehabilitation].[临床实践中心血管疾病预防指南。比利时心血管预防与康复工作组]
Rev Med Brux. 2009 Jan-Feb;30(1):37-46.

引用本文的文献

1
Epidemiological Analysis of Cardiovascular Diseases with Consideration of Risk Factors, Health Awareness, and Preventive Behaviors in Civilian and Military Populations.考虑平民和军人群体的危险因素、健康意识及预防行为的心血管疾病流行病学分析
J Clin Med. 2025 Aug 18;14(16):5844. doi: 10.3390/jcm14165844.
2
Recommendations for sample selection, collection and preparation for NMR-based metabolomics studies of blood.基于核磁共振的血液代谢组学研究的样本选择、采集及制备建议
Metabolomics. 2025 May 10;21(3):66. doi: 10.1007/s11306-025-02259-7.
3
Cardiovascular risk profile with SCORE2 and SCORE2-OP: comparing Portugal, Spain, Italy, and France using the new European predictive models.
使用SCORE2和SCORE2-OP评估心血管风险状况：运用新的欧洲预测模型比较葡萄牙、西班牙、意大利和法国
Front Cardiovasc Med. 2024 Dec 18;11:1509240. doi: 10.3389/fcvm.2024.1509240. eCollection 2024.
4
Baseline inflammatory status affects the prognostic impact of statins in patients with peripheral arterial disease.基线炎症状态影响他汀类药物对周围动脉疾病患者的预后影响。
Am Heart J Plus. 2024 Oct 30;47:100481. doi: 10.1016/j.ahjo.2024.100481. eCollection 2024 Nov.
5
Machine learning models to predict 30-day mortality for critical patients with myocardial infarction: a retrospective analysis from MIMIC-IV database.预测急性心肌梗死重症患者30天死亡率的机器学习模型：来自MIMIC-IV数据库的回顾性分析
Front Cardiovasc Med. 2024 Sep 20;11:1368022. doi: 10.3389/fcvm.2024.1368022. eCollection 2024.
6
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial.多因素干预对 DKD 患者心血管和死亡风险的性别差异：一项随机临床试验的事后分析。
Cardiovasc Diabetol. 2024 Aug 5;23(1):285. doi: 10.1186/s12933-024-02371-3.
7
Cardiovascular risk and subclinical atherosclerosis in first-degree relatives of patients with premature cardiovascular disease.早发性心血管疾病患者一级亲属的心血管风险与亚临床动脉粥样硬化
Am J Prev Cardiol. 2024 Jul 4;19:100704. doi: 10.1016/j.ajpc.2024.100704. eCollection 2024 Sep.
8
Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease.非空腹脂蛋白和载脂蛋白在中国冠心病患者中的临床及预后价值
Rev Cardiovasc Med. 2023 Nov 9;24(11):314. doi: 10.31083/j.rcm2411314. eCollection 2023 Nov.
9
Noncommunicable Disease Conditions and HIV in Rural and Urban South Africa: 2005-2015.南非农村和城市地区的非传染性疾病状况和艾滋病毒：2005-2015 年。
Ethn Dis. 2024 Apr 10;33(2-3):108-115. doi: 10.18865/ed.33.2-3.108. eCollection 2023 Apr.
10
A Preliminary Study on Hepatoprotective, Hypolipidemic and Aortic Morphometric Effects of Omega-3-Rich Fish Oil in Hypercholesterolemic Mice.富含Omega-3的鱼油对高胆固醇血症小鼠的肝脏保护、降血脂及主动脉形态学影响的初步研究
Pharmaceuticals (Basel). 2024 Jan 6;17(1):72. doi: 10.3390/ph17010072.